Latest Regulatory Environment News

Page 23 of 41
Equity Trustees reports record funds under management of $254 billion and a 60% jump in statutory net profit, completing a transformative three-year strategic agenda.
Claire Turing
Claire Turing
21 Aug 2025
EQT Holdings Limited reported a robust FY25 with a 60% jump in net profit and record funds under management, while completing a major acquisition integration and raising dividends.
Claire Turing
Claire Turing
21 Aug 2025
Xamble Group Limited (ASX, XGL) has announced a pro-rata renounceable entitlement offer to raise up to A$1.36 million, including free attaching options exercisable until 2028. The offer is partially underwritten by Eli Capital Pty Limited and aims to accelerate platform growth and technology development.
Sophie Babbage
Sophie Babbage
20 Aug 2025
The Papua New Guinea Mining Advisory Committee has recommended extending St Barbara's Simberi Mining Lease to 2038, aligning with plans to boost gold production beyond 200,000 ounces annually.
Maxwell Dee
Maxwell Dee
19 Aug 2025
Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.
Ada Torres
Ada Torres
18 Aug 2025
Bank of Queensland Limited announces a fully franked quarterly distribution of AUD 1.337 per Capital Note 3 security, payable in November 2025. The payment reflects a total annualised rate of 5.19%, based on the 3-month BBSW plus margin, adjusted for franking credits.
Victor Sage
Victor Sage
18 Aug 2025
Aurizon Holdings reported a 3% decline in underlying EBITDA and a 14% drop in NPAT for FY2025, while unveiling a $150 million on-market buy-back and a $500 million subordinated notes issuance to strengthen its balance sheet.
Victor Sage
Victor Sage
18 Aug 2025
Aurizon Holdings reported a modest 3% decline in FY2025 underlying EBITDA, weighed down by Bulk segment setbacks, while announcing a robust FY2026 earnings forecast and a $150 million share buy-back.
Victor Sage
Victor Sage
18 Aug 2025
Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.
Ada Torres
Ada Torres
15 Aug 2025
Cochlear Limited has announced a fully franked ordinary dividend of AUD 2.15 per share for the six months ending June 2025, payable in October with multi-currency options for shareholders.
Ada Torres
Ada Torres
15 Aug 2025
BPH Energy has responded to an ASX price query following unusual trading activity, confirming no undisclosed information exists and pointing to ongoing legal matters involving its investee Advent Energy as context.
Maxwell Dee
Maxwell Dee
14 Aug 2025
Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $1.45 million, aimed at funding early development and exploration activities in Tanzania. The offer includes free attaching options and is partially underwritten, with significant implications for shareholder dilution and company control.
Maxwell Dee
Maxwell Dee
14 Aug 2025